Collaboration in Healthcare

We view strategic collaborations as integral to transforming the lives of patients with serious medical needs around the world. Together with our partners, we bring healthcare innovations to life.


Healthcare Innovation Starts with Collaboration

If you're searching for a strong partner for your next project, look no further than Merck KGaA, Darmstadt, Germany. Whether it’s an early-stage licensing opportunity, new technology or strategic research alliance, we’re actively seeking partnerships with like-minded organizations – those that value trust, transparency and mutually rewarding relationships, with the ambition to increase the value of each partnership.We are focused on broadening our access to the world of scientific and product innovation beyond our own laboratories, and are interested in extending our global and regional commercial portfolio. If you are looking for a partner either to bring your competitive portfolio of investigational products to the market, or to fully exploit the potential of your commercial products, we’d love to hear from you.

Learn more about our Strategic Focus & Partnerships

In a collaborative and innovative culture, we combine our internal capabilities and expertise with leading external enterprises.

Philippe Lopes-Fernandes

Senior Vice President
Head of Global Business Development & Alliance Management

Strategy in Action

In order to achieve our strategic business objectives, we are aiming to invest energy and resources in the following partnerships, key franchises and markets.

Building our Bench Strength

Partnerships strengthen our Pipeline

Partnerships strengthen our Pipeline

Focusing on our Key Franchises

Focusing on our Key Franchises

Expanding our geographic Presence

Expanding our geographic Presence

For further information in partnering with us, please visit here.

We believe in the innovative power of collaboration. We are actively seeking new strategic partnerships, and will consider all opportunities that have the potential to create value using innovative deal structures and creative alliances. Take a deeper dive into our key areas and partnerships.

Learn more about collaborating with us

Accelerating innovation

We are committed to a collaborative R&D model, forging partnerships with academic, research institutions, and biotech and pharma companies to bring new therapies to patients. With roughly 50% of our pipeline developed through collaborations, we value the innovative spirit that exists both inside our walls and around the ecosystem of healthcare.

Related News

View All News
  1. Press Releases

    BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New ...

    Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono, Inc. in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the..

    2020/09/18

  2. Press Releases

    Merck KGaA, Darmstadt, Germany, Advances Oncology Portfolio and Pipeline with ...

    Merck KGaA, Darmstadt, Germany, today announced more than 30 abstracts will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 from September 19-21. The abstracts span ...

    2020/09/14

  3. Press Releases

    Merck KGaA, Darmstadt, Germany Announces Positive Phase II Results for Investigational ...

    Merck KGaA, Darmstadt, Germany today announced positive top-line results from a Phase II study of sonelokinab (M1095), an investigational anti-IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F.

    2020/09/10

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement